ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ACHV Achieve Life Sciences Inc

4.50
-0.02 (-0.44%)
Last Updated: 15:58:15
Delayed by 15 minutes
Share Name Share Symbol Market Type
Achieve Life Sciences Inc NASDAQ:ACHV NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.02 -0.44% 4.50 4.45 4.50 4.533 4.35 4.52 13,407 15:58:15

Initial Statement of Beneficial Ownership (3)

13/10/2020 4:53pm

Edgar (US Regulatory)


FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Wann Jerry
2. Date of Event Requiring Statement (MM/DD/YYYY)
9/28/2020 

3. Issuer Name and Ticker or Trading Symbol

ACHIEVE LIFE SCIENCES, INC. [ACHV]
(Last)        (First)        (Middle)

1040 WEST GEORGIA STREET, SUITE 1030
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Principal Accounting Officer /
(Street)

VANCOUVER, A1 V6E 4H1      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 89 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Wann Jerry
1040 WEST GEORGIA STREET
SUITE 1030
VANCOUVER, A1 V6E 4H1


Principal Accounting Officer

Signatures
Sandra Thomson Attorney-in-Fact for Jerry Wan10/13/2020
**Signature of Reporting PersonDate

1 Year Achieve Life Sciences Chart

1 Year Achieve Life Sciences Chart

1 Month Achieve Life Sciences Chart

1 Month Achieve Life Sciences Chart

Your Recent History

Delayed Upgrade Clock